Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I and Iimidazoline drugs

Journal of Psychopharmacology

Volumn 29, Issue 9, 2015, Pages 996-1012

  Keller, Benjamin ^a,b   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

human platelets; Imidazoline receptors; mouse and human brains; neuron and astrocyte cells; treatments with Iand Idrugs in mice

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; ANTIBODY; EFAROXAN; IDAZOXAN; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE I2 RECEPTOR; IMIDAZOLINE RECEPTOR BINDING PROTEIN ANTIBODY; MOXONIDINE; NISCH ANTIBODY; NISCHARIN ANTIBODY; TRACIZOLINE; UNCLASSIFIED DRUG; 2-STYRYL-2-IMIDAZOLINE; BENZOFURAN DERIVATIVE; IMIDAZOLE DERIVATIVE; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTORS; IMIDAZOLINE RECEPTOR; STYRENE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOMODULATION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POST MORTEM PROTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THROMBOCYTE; UPREGULATION; WHITE MATTER; ANIMAL; BINDING SITE; BRAIN; CELL MEMBRANE; CYTOSOL; DRUG EFFECTS; FEMALE; METABOLISM;

ADULT; ANIMALS; ANTIBODIES; BENZOFURANS; BINDING SITES; BRAIN; CELL MEMBRANE; CYTOSOL; FEMALE; HUMANS; IDAZOXAN; IMIDAZOLES; IMIDAZOLINE RECEPTORS; IMIDAZOLINES; MALE; MICE; STYRENES; UP-REGULATION;

EID: 84942107261     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115586936     Document Type: Article

References (88)

1. Aceros H, Farah G, Noiseux N, et al. (2014) Moxonidine modulates cytokine signaling and effects on cardiac cell viability. Eur J Pharmacol 740C: 168-182.
2. Alahari SK, Lee JW, Juliano RL, (2000) Nischarin, a novel protein that interacts with the integrin α5 subunit and inhibits cell migration. J Cell Biol 151: 1141-1154.
3. Alemany R, Olmos G, García-Sevilla JA, (1997) Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: Characterization, regulation and relation to monoamine oxidase enzymes. Naunyn Schmiedeberg€™s Arch Pharmacol 356: 39-47.
4. Álvaro-Bartolomé M, García-Sevilla JA, (2013) Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents. Neuroscience 247: 294-308.
5. Anderson NJ, Tyacke RJ, Husbands SM, et al. (2006) In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain. Neuropharmacology 50: 269-276.
6. Barturen F, Ventayol P, Ozaita A, et al. (1999) Densities of I2-imidazoline receptors, imidazoline receptor proteins, and MAO-B sites in human gliomas and pituitary adenomas. Ann N Y Acad Sci 881: 203-207.
7. Bennai F, Greney H, Molines A, et al. (1995) Antiidiotypic antibodies as tools to study imidazoline receptors. Ann N Y Acad Sci 763: 140-148.
8. Bennai F, Greney H, Vonthron C, et al. (1996) Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites. Eur J Pharmacol 306: 211-218.
9. Boronat MA, Olmos G, Miller DD, et al. (1998) Isothiocyanatobenzyl imidazoline is an alkylating agent for I2-imidazoline binding sites in rat and rabbit tissues. Naunyn Schmiedebergs Arch Pharmacol 357: 351-355.
10. Bousquet P, (1995) Imidazoline receptors: From basic concepts to recent developments. J Cardiovasc Pharmacol 26: S1-S6.
11. Casanovas A, Olmos G, Ribera J, et al. (2000) Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2-imidazoline receptor ligand LSL60101. Br J Pharmacol 130: 1767-1776.
12. Chan SL, Brown CA, Scarpello KE, et al. (1994) The imidazoline site involved in control of insulin secretion: Characteristics that distinguish it from I1- and I2-sites. Br J Pharmacol 112: 1065-1070.
13. Chen MJ, Zhu HE, Piletz JE, (2003) Intracellular effect of imidazoline receptor on α2A-noradrenergic receptor. Ann NY Acad Sci 1009: 427-438.
14. Chen MF, Tsai JT, Chen LJ, et al. (2014) Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents. Biomed Res Int 2014: Article ID 182846. doi: 10.1155/2014/182846.
15. Coates PA, Grundt P, Robinson ES, et al. (2000) Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett 10: 605-607.
16. Ding Y, Zhang R, Zhang K, et al. (2013) Nischarin is differentially expressed in rat brain and regulates neuronal migration. PloS One 8: e54563. DOI: 10.1371/journal.pone.0054563.
17. Dontenwill M, Pascal G, Piletz JE, et al. (2003a) IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells. Cell Death Differ 10: 933-935.
18. Dontenwill M, Piletz JE, Chen M, et al. (2003b) IRAS is an anti-apoptotic protein. Ann NY Acad Sci 1009: 400-412.
19. Edwards L, Fishman D, Horowitz P, et al. (2001) The imidazoline-1 receptor in PC12 pheochromocytoma cells activates protein kinase C, extracellular signal-regulated kinsase (ERK) and c-jun N-terminal kinsase (JNK). J Neurochem 79: 931-940.
20. El-Ayoubi R, Gutkowska J, Regunathan S, et al. (2002) Imidazoline receptors in the heart: characterization, distribution, and regulation. J Cardiovasc Pharmacol 39: 875-883.
21. El-Ayoubi R, Menaouar A, Gutkowska J, et al. (2003) Normalization of up-regulated cardiac imidazoline I(1)-receptors and natriuretic peptides by chronic treatment with moxonidine in spontaneously hypertensive rats. Ann N Y Acad Sci 1009: 274-278.
22. El-Ayoubi R, Menaouar A, Gutkowska J, et al. (2004) Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment. J Pharmacol Exp Ther 310: 446-451.
23. Eng LF, Ghirnikar RS, Lee YL, (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 9-10: 1439-1451.
24. Ernsberger P, Graves ME, Graff LM, et al. (1995) I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling. Ann N Y Acad Sci 763: 22-42.
25. Escribá PV, Sastre M, Wang H, et al. (1994) Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci Lett 178: 81-84.
26. Escribá PV, Ozaita A, Miralles A, et al. (1995) Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Brain Res Mol Brain Res 32: 187-196.
27. Escribá PV, Alemany R, Sastre M, et al. (1996) Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: Relationship with non-adrenoceptor [3H]-idazoxan binding sites. Br J Pharmacol 118: 2029-2036.
28. Escribá PV, Ozaita A, García-Sevilla JA, (1999) Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Ann NY Acad Sci 881: 8-25.
29. Ferrer-Alcón M, García-Fuster MJ, La Harpe R, et al. (2004) Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts. J Neurochem 90: 220-230.
30. Garau C, Miralles A, García-Sevilla JA, (2013) Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain. J Psychopharmacol 27: 123-134.
31. García-Sevilla JA, Meana JJ, Barturen F, et al. (1993) New 2-benzofuranyl-imidazole derivatives with imidazoline receptor affinity, used as appetite stimulants or anti-anorexics. UK patent GB2262739-A. Derwent primary accession number: 1993-207864.
32. García-Sevilla JA, Sastre M, Escribá PV, (1995a) Age-dependent increases of immunoreactive imidazoline receptors in the human brain: possible association of a 29/30 kDa protein with the I2-imidazoline receptor identified by [3H]idazoxan. Neurosci Lett 184: 133-136.
33. García-Sevilla JA, Miralles A, Sastre M, et al. (1995b) I2-imidazoline receptors in the healthy and pathologic human brain. Ann N Y Acad Sci 763: 178-193.
34. García-Sevilla JA, Escribá PV, Sastre M, et al. (1996a) Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiatry 53: 803-810.
35. García-Sevilla JA, Escribá PV, Busquets X, et al. (1996b) Platelet imidazoline receptors and regulatory G proteins in patients with major depression. Neuroreport 8: 169-172.
36. García-Sevilla JA, Escribá PV, Walzer C, et al. (1998) Imidazoline receptor proteins in brains of patients with Alzheimer€™s disease. Neurosci Lett 247: 95-98.
37. García-Sevilla JA, Escribá PV, Guimón J, (1999) Imidazoline receptors and human brain disorders. Ann NY Acad Sci 21: 392-409.
38. García-Sevilla JA, Ferrer-Alcón M, (2003) In vivo effects of the I2-alkylating agent BU99006 on the immunodensity of imidazoline receptor proteins in the mouse brain. Ann NY Acad Sci 1009: 323-331.
39. García-Sevilla JA, Álvaro-Bartolomé M, Díez-Alarcia R, et al. (2010) Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients. Eur Neuropsychopharmacol 20: 721-730.
40. Halaris A, Zhu H, Feng Y, et al. (1999) Plasma agmatine and platelet imidazoline receptors in depression. Ann NY Acad Sci 881: 445-451.
41. Harlow E, Lane D, (1999) Using antibodies. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
42. Hu LA, Zhou T, Ahn J, et al. (2009) Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. Biochem J 424: 39-45.
43. Hudson AL, Gough RE, Tyacke R, et al. (1999) Novel selective compounds for the investigation of imidazoline receptors. Ann NY Acad Sci 881: 81-91.
44. Ivanov TR, Zhu H, Regunathan S, et al. (1998a) Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem Pharmacol 55: 649-655.
45. Ivanov TR, Feng Y, Wang H, et al. (1998b) Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J Psychiatr Res 32: 65-79.
46. Kim YH, Nam TS, Ahn DS, et al. (2011) Modulation of N-type Ca2 a currents by moxonidine via imidazoline I1 receptor activation in rat superior cervical ganglion neurons. Biochem Biophys Res Commun 409: 645-650.
47. Kimura A, Tyacke RJ, Robinson JJ, et al. (2009) Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site. Brain Res 1279: 21-28.
48. Lanier SM, Ivkovic B, Singh I, et al. (1993) Visualization of multiple imidazoline/guanidinium-receptive sites. J Biol Chem 268: 16047-16051.
49. Li J-X, Zhang Y, (2011) Imidazoline I2 receptors: Target for new analgesics? Eur J Pharmacol 658: 49-56.
50. Lim K-P, Hong W, (2004) Human Nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region. J Biol Chem 279: 54770-54782.
51. Lione LA, Nutt DJ, Hudson AL, (1998) Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: A selective ligand for imidazoline I2 receptors. Eur J Pharmacol 353: 123-135.
52. Ma JK, Zhu HE, Piletz JE, (2003) Effect of postmortem delay on imidazoline receptor-binding proteins in human and mouse brain. Ann N Y Acad Sci 1009: 341-346.
53. Mar GY, Chou MT, Chung HH, et al. (2013) Changes of imidazoline receptors in spontaneously hypertensive rats. Int J Exp Pathol 94: 17-24.
54. Meana JJ, Barturen F, García-Sevilla JA, (1989) Characterization and regional distribution of α2-adrenoceptors in postmortem human brain using the full agonist [3H]UK 14304. J Neurochem 52: 1210-1217.
55. Miralles A, Olmos G, Sastre M, et al. (1993) Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J Pharmacol Exp Ther 264: 1187-1197.
56. Molderings GJ, Bönisch H, Bruss M, et al. (2007) S1P-receptors in PC12 and transfected HEK293 cells: Molecular targets of hypotensive imidazoline I(1) receptor ligands. Neurochem Int 51: 476-485.
57. Nutt DJ, French N, Handley S, et al. (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann NY Acad Sci 763: 125-139.
58. Olmos G, Miralles A, Barturen F, et al. (1992) Characterization of brain imidazoline receptors in normotensive and hypertensive rats: Differential regulation by chronic imidazoline drug treatment. J Pharmacol Exp Ther 260: 1000-1007.
59. Olmos G, Alemany R, Escribá PV, et al. (1994) The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br J Pharmacol 111: 997-1002.
60. Olmos G, Alemany R, Boronat MA, et al. (1999a) Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes. Ann N Y Acad Sci 881: 144-160.
61. Olmos G, DeGregorio-Rocasolano N, Regalado PM, et al. (1999b) Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127: 1317-1326.
62. Ozaita A, Olmos G, Boronat MA, et al. (1997) Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br J Pharmacol 121: 901-912.
63. Paterson LM, Tyacke RJ, Robinson ES, et al. (2007) In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: Evidence for two distinct I2 binding sites. Neuropharmacology 52: 395-404.
64. Piletz JE, Jones JC, Zhu H, et al. (1999) Imidazoline receptor antisera-selected cDNA clone and mRNA distribution. Ann N Y Acad Sci 881: 1-7.
65. Piletz JE, Zhu H, Ordway G, et al. (2000a) Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol Psychiatry 48: 910-919.
66. Piletz JE, Ivanov TR, Sharp JD, et al. (2000b) Imidazoline receptor antisera-selected (IRAS) cDNA: Cloning and characterization. DNA Cell Biol 19: 319-329.
67. Piletz JE, Deleersnijder W, Roth BL, et al. (2003a) IRAS splice variants. Ann N Y Acad Sci 1009: 419-426.
68. Piletz JE, Wang G, Zhu H,. (2003b) Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. Ann N Y Acad Sci 1009: 392-399.
69. Polidori C, Gentili F, Pigini M, et al. (2000) Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites. Eur J Pharmacol 392: 41-49.
70. Raddatz R, Parini A, Lanier SM, (1995) Imidazoline/guanidium binding domains on monoamine oxidases. J Biol Chem 270: 27961-27968.
71. Raddatz R, Parini A, Lanier SM, (1997) Localization of the imidazoline binding domain on monoamine oxidase B. Mol Pharmacol 52: 549-553.
72. Regunathan S, Feinstein DL, Reis DJ, (1993) Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J Neurosci Res 34: 681-688.
73. Regunathan S, Reis DJ, (1996) Imidazoline receptors and their endogenous ligands. Ann Rev Pharmacol Toxicol 36: 511-544.
74. Ruggiero DA, Reguhathan S, Wang H, et al. (1995) Distribution of imidazoline receptor binding protein in the central nervous system. Ann NY Acad Sci 763: 208-221.
75. Ruggiero DA, Reguhathan S, Wang H, et al. (1998) Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res 780: 270-293.
76. Ruiz J, Martín I, Callado LF, et al. (1993) Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer€™s disease. Neurosci Lett 160: 109-112.
77. Sano H, Liu SC, Lane WS, et al. (2002) Insulin receptor substrate 4 associates with the protein IRAS. J Biol Chem 277: 19439-19447.
78. Sastre M, Ventayol P, García-Sevilla JA, (1996) Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts. Neuroreport 7: 509-512.
79. Sun Z, Chang CH, Ernsberger P, (2007) Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells. J Neurochem 101: 99-108.
80. Tyacke RJ, Robinson ES, Nutt DJ, et al. (2002) 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline-2 binding site ligand: In vitro and in vivo characterisation in rat brain. Neuropharmacology 43: 75-83.
81. Wang H, Regunathan S, Meeley MP, et al. (1992) Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol Pharmacol 42: 792-801.
82. Wang H, Regunathan S, Ruggiero DA, et al. (1993) Production and characterization of antibodies specific for the imidazoline receptor protein. Mol Pharmacol 43: 509-515.
83. Wang B, Liu Y, Shan Y, et al. (2009) Generation and characterization of novel human IRAS monoclonal antibodies. J Biomed Biotechnol 2009: Article ID 973754.
84. Wang LY, Ku PM, Chen SH, et al. (2013) Characterization of the specificity of imidazoline I-1 receptor antibody for subtype of imidazoline receptors in vitro. Horm Metab Res 45: 485-489.
85. Zhang J, Abdel-Rahman AA, (2006) Nischarin as a functional imidazoline (I1) receptor. FEBS Lett 580: 3070-3074.
86. Zhang J, Abdel-Rahman AA, (2008) Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signal-regulated kinase 1/2 production in the rostral ventrolateral medulla of rats. J Pharmacol Exp Ther 324: 72-78.
87. Zhang L, Zhao TY, Hou N, et al. (2013) Generation and primary phenotypes of imidazoline receptor antisera-selected (IRAS) knockout mice. CNS Neurosci Ther 19: 978-981.
88. Ziegler D, Haxhiu MA, Kaan EC, et al. (1996) Pharmacology of moxonidine, an I1-imidazoline receptor agonist. J Carciovasc Pharmacol 27: S26-S37.